{"id":"https://openalex.org/W4362411409","doi":"https://doi.org/10.1158/1078-0432.22479674","title":"Figure S3 from Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity","display_name":"Figure S3 from Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4362411409","doi":"https://doi.org/10.1158/1078-0432.22479674"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22479674","doi":"https://doi.org/10.1158/1078-0432.22479674","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22479674","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S3_from_Phase_I_Clinical_Trial_of_Combination_Propranolol_and_Pembrolizumab_in_Locally_Advanced_and_Metastatic_Melanoma_Safety_Tolerability_and_Preliminary_Evidence_of_Antitumor_Activity/22479674/1/files/39931178.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S3_from_Phase_I_Clinical_Trial_of_Combination_Propranolol_and_Pembrolizumab_in_Locally_Advanced_and_Metastatic_Melanoma_Safety_Tolerability_and_Preliminary_Evidence_of_Antitumor_Activity/22479674/1/files/39931178.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064151962","display_name":"Shipra Gandhi","orcid":"https://orcid.org/0000-0003-3506-0284","observed_orcids":["https://orcid.org/0000-0003-3506-0284"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shipra Gandhi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089941327","display_name":"Manu Raj Pandey","orcid":"https://orcid.org/0000-0002-5276-3806","observed_orcids":["https://orcid.org/0000-0002-5276-3806"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manu R. Pandey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011054139","display_name":"Kristopher M. Attwood","orcid":"https://orcid.org/0000-0002-7229-5472","observed_orcids":["https://orcid.org/0000-0002-7229-5472","https://orcid.org/0009-0003-3874-1293"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristopher Attwood","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Wenyan Ji","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wenyan Ji","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034535391","display_name":"Agnieszka Katarzyna Witkiewicz","orcid":"https://orcid.org/0000-0003-4538-1145","observed_orcids":["https://orcid.org/0000-0003-4538-1145"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Agnieszka K. Witkiewicz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029801038","display_name":"Erik S. Knudsen","orcid":"https://orcid.org/0000-0002-5130-5969","observed_orcids":["https://orcid.org/0000-0002-5130-5969"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erik S. Knudsen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5130-5969","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110967141","display_name":"Cheryl L. Allen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cheryl Allen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053887896","display_name":"Joseph Dennis Tario","orcid":"https://orcid.org/0009-0009-2145-6617","observed_orcids":["https://orcid.org/0009-0009-2145-6617"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph D. Tario","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065404552","display_name":"Paul K. Wallace","orcid":"https://orcid.org/0000-0001-7823-9917","observed_orcids":["https://orcid.org/0000-0001-7823-9917"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul K. Wallace","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109602063","display_name":"Carlos D. Cedeno","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carlos D. Cedeno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058935510","display_name":"Maria Levis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Levis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078413773","display_name":"Suzanne M. Stack","orcid":"https://orcid.org/0000-0003-4256-8035","observed_orcids":["https://orcid.org/0000-0003-4256-8035"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suzanne Stack","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4256-8035","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057402683","display_name":"Pauline Funchain","orcid":"https://orcid.org/0000-0002-7568-8626","observed_orcids":["https://orcid.org/0000-0002-7568-8626"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pauline Funchain","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018176156","display_name":"Joseph J. Drabick","orcid":"https://orcid.org/0000-0002-7630-2721","observed_orcids":["https://orcid.org/0000-0002-7630-2721"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph J. Drabick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078984239","display_name":"Mark J. Bucsek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark J. Bucsek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049243227","display_name":"Igor J. Puzanov","orcid":"https://orcid.org/0000-0002-9803-3497","observed_orcids":["https://orcid.org/0000-0002-9803-3497"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Igor Puzanov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071658240","display_name":"Hemn Mohammadpour","orcid":"https://orcid.org/0000-0002-0158-7283","observed_orcids":["https://orcid.org/0000-0002-0158-7283"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hemn Mohammadpour","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029344793","display_name":"Elizabeth A. Repasky","orcid":"https://orcid.org/0000-0002-9554-4152","observed_orcids":["https://orcid.org/0000-0002-9554-4152"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth A. Repasky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5089516753","display_name":"Marc S. Ernstoff","orcid":"https://orcid.org/0000-0002-8132-7069","observed_orcids":["https://orcid.org/0000-0002-8132-7069"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marc S. Ernstoff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9470000267028809},{"id":"https://openalex.org/keywords/propranolol","display_name":"propranolol","score":0.746999979019165},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/immune-infiltration","display_name":"immune cell infiltration","score":0.7390000224113464},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.949999988079071},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9319999814033508},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.781000018119812},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.949999988079071},{"id":"https://openalex.org/keywords/t-helper-cells","display_name":"T helper cells","score":0.6980000138282776},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.5040000081062317}],"concepts":[{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.8261278867721558},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.794973611831665},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7454568147659302},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5562599897384644},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5434122681617737},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5063632726669312},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4950837194919586},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4416671395301819},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.42533108592033386},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25218474864959717},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.13290905952453613},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22479674","doi":"https://doi.org/10.1158/1078-0432.22479674","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22479674","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S3_from_Phase_I_Clinical_Trial_of_Combination_Propranolol_and_Pembrolizumab_in_Locally_Advanced_and_Metastatic_Melanoma_Safety_Tolerability_and_Preliminary_Evidence_of_Antitumor_Activity/22479674/1/files/39931178.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22479674","doi":"https://doi.org/10.1158/1078-0432.22479674","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22479674","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Figure_S3_from_Phase_I_Clinical_Trial_of_Combination_Propranolol_and_Pembrolizumab_in_Locally_Advanced_and_Metastatic_Melanoma_Safety_Tolerability_and_Preliminary_Evidence_of_Antitumor_Activity/22479674/1/files/39931178.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362411409.pdf","grobid_xml":"https://content.openalex.org/works/W4362411409.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362411452","https://openalex.org/W4361939052","https://openalex.org/W4232093254","https://openalex.org/W4362432265","https://openalex.org/W2521050684","https://openalex.org/W4361814561","https://openalex.org/W2615188404","https://openalex.org/W2896078600","https://openalex.org/W4361939064","https://openalex.org/W2103277177"],"abstract_inverted_index":{"Multispectral":[0],"staining":[1],"of":[2],"the":[3,17],"immune":[4,18],"cell":[5,19],"infiltrate":[6],"in":[7,16,34],"melanoma.":[8],"A,":[9],"Low":[10],"power":[11],"magnification":[12,23],"depicting":[13],"marked":[14],"variability":[15],"types.":[20],"B,":[21],"Higher":[22],"showing":[24],"PDL1":[25],"expression":[26],"on":[27],"melanoma":[28,37,45,67],"cells":[29,46,58,75],"(arrow)":[30],"and":[31,38,59,76],"multiple":[32],"m-MDSCs":[33],"contact":[35],"with":[36,68],"CD8+":[39,60,69],"T":[40,53,56,62,71,73],"cells.":[41,63],"C,":[42],"PD-L1":[43,65],"expressing":[44],"(arrows)":[47],"are":[48],"infiltrated":[49],"by":[50],"PMN-MDSCs,":[51],"regulatory":[52],"cells,":[54,72],"CD4+":[55],"helper":[57,74],"cytotoxic":[61,70],"D,":[64],"negative":[66],"m-MDSCs.":[77]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2023-04-05T00:00:00"}